| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Outline of Final Research Achievements |
Although biliary atresia (BA) patients can get a long-term survival by Kasai portoenterostomy, some BA patients progress to native liver failure in adulthood. The result of liver transplantation in adult BA patients is poorer than that of in pediatric BA patients. In addition, most adult BA patients cannot have liver transplantation by absence of living donor and impossibility of deceased donor registration. In this study, we evaluated a telomere length of hepatocyte of school-age BA patients because existing hepatocellular reserve biomarkers cannot predict the future native liver failure. These patients with normal results of existing hepatocellular reserve biomarkers showed a shortening of telomere length of hepatocyte. Therefore, we could judge a relative indication of liver transplantation. Telomere length analysis using quantitative fluorescence in situ hybridization could be an objective indicator of hepatocellular reserve capacity in BA patients.
|
